ストックスクリーナーアプリを入手
0.4043
8.11%
-0.0357
アフターアワーズ：
.40
-0.0043
-1.06%
Prophase Labs Inc (PRPH) 最新ニュース
Earnings call transcript: ProPhase Labs Q4 2024 earnings miss, stock falls - Investing.com
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024 - The Manila Times
ProPhase Labs Pivots Business Model After $53M Loss: Cancer Test Launch Takes Center Stage - Stock Titan
ProPhase Labs (PRPH) Set to Announce FY Earnings, Faces Challenges - GuruFocus.com
An Overview of ProPhase Labs's Earnings - Benzinga
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025 - The Manila Times
ProPhase Labs Announces Key Full Year 2024 Financial Results PresentationVirtual Access Available - Stock Titan
ProPhase Labs (PRPH) Projected to Post Earnings on Thursday - Defense World
ProPhase Labs, Inc. CEO Ted Karkus to Present at Q1 Investor Summit Virtual on March 11th - Nasdaq
ProPhase Labs to Present at the Investor Summit Virtual on March 11 - GlobeNewswire
Can ProPhase Labs Convince Investors? CEO Reveals Strategic Vision Next Week - StockTitan
Bears are Losing Control Over ProPhase Labs (PRPH), Here's Why It's a 'Buy' Now - Yahoo Finance
ProPhase Labs, Inc. to Host Earnings Call - ACCESS Newswire
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - EIN News
Deeper Dive: Understanding ProPhase Labs Inc (PRPH) Through its Various Ratios - The Dwinnex
ProPhase Labs Examines Strategic Opportunities to Leverage - GlobeNewswire
ProPhase Labs Focuses On Telehealth And DTC Marketing For Prescription Drug Growth Strategy - Nasdaq
ProPhase Labs examines opportunities to leverage DTC multi-media infrastructure - TipRanks
ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs - The Manila Times
Can ProPhase's Telehealth Pivot Save Its Stock From Delisting? Company Says No Reverse Split Needed - StockTitan
ProPhase Labs (NASDAQ:PRPH) Now Covered by Analysts at StockNews.com - Defense World
ProPhase sharpens focus on direct-to-consumer growth - Investing.com
ProPhase Labs Appoints Stuart Hollenshead as COO - TipRanks
ProPhase Labs Announces Excellent Progress with Crown - GlobeNewswire
ProPhase Labs Targets Immediate Cash Generation With COVID-19 Receivables And Asset Sales - Nasdaq
Can ProPhase Labs Transform $150M in COVID Claims into a $50M Windfall? - StockTitan
ProPhase Labs hires former Barstool Sports COO Stuart Hollenshead, plans cost-cutting measures - MSN
ProPhase Labs hires Stuart Hollenshead as COO - TipRanks
ProPhase Labs appoints Stu Hollenshead as COO By Investing.com - Investing.com Nigeria
ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports - GlobeNewswire
ProPhase Labs Appoints Stu Hollenshead as Chief Operating Officer -February 18, 2025 at 09:45 am EST - Marketscreener.com
ProPhase Labs shares rise on cost cutting plans, hires former Barstool Sports COO Stu Hollenshead - Seeking Alpha
ProPhase Labs appoints Stu Hollenshead as COO - Investing.com
Barstool Sports Executive Powerhouse Joins ProPhase Labs: Major Push into 70M Women Health Market - StockTitan
ProPhase Labs FY2024 EPS Estimate Reduced by Diamond Equity - Defense World
ProPhase Labs (NASDAQ:PRPH) Now Covered by StockNews.com - Defense World
ProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles - MSN
ProPhase Labs Appoints New Chief Operating Officer - TipRanks
ProPhase Labs appoints new COO amid executive changes By Investing.com - Investing.com South Africa
ProPhase Labs appoints new COO amid executive changes - MSN
Why AppLovin Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket - Benzinga
StockNews.com Begins Coverage on ProPhase Labs (NASDAQ:PRPH) - Defense World
Following A -1.03% Weekly Decline, Is It Still A Buy For ProPhase Labs Inc (NASDAQ: PRPH)? - Marketing Sentinel
ProPhase Labs Inc [PRPH] moved up 1.41: Why It’s Important - The DBT News
PRPH’s Q2 earnings predictions: What the experts say - US Post News
ProPhase Labs Enters into Common Stock Purchase Agreement with Equity Line Investor - Defense World
ProPhase Labs (NASDAQ:PRPH) Coverage Initiated by Analysts at StockNews.com - Defense World
ProPhase Labs stock hits 52-week low at $0.41 amid sharp decline - MSN
ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates - MSN
1.12%
1.76%
大文字化:
|
ボリューム (24 時間):